The 20 Best Diabetic Retinopathy Doctors Near Me in Ann Arbor, MI

Thomas Gardner is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Gardner is rated as an Elite provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.

Dr. Shah earned her medical degree from the University of Michigan Medical School in 2006 and completed her residency in ophthalmology at the Cullen Eye Institute, Baylor College of Medicine in 2010. She was a medical retina fellow at New England Eye Center, Tufts University School of Medicine, followed by 2 years in private practice in the Boston area before joining the faculty at W.K. Kellogg Eye Center in 2013. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Diabetic Retinopathy, Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). Dr. Shah is board certified in Ophthalmology.

David N. Zacks completed his undergraduate degree at Cornell University, where he majored in neurobiology. This was followed by a combined M.D. and Ph.D. from the Albert Einstein College of Medicine in Bronx, New York. He finished his ophthalmology residency in 2000 and his vitreo-retinal fellowship in 2002, both at the Massachusetts Eye and Ear Infirmary in Boston, Massachusetts. Dr. Zacks joined the Retina Service of the University of Michigan’s Kellogg Eye Center in 2002. His clinical activity focuses on diseases and surgery of the retina. His main research interest is in the molecular control of photoreceptor cell death during retinal disease. He holds (or has held) research grants from the National Eye Institute, Research to Prevent Blindness, Inc., Foundation Fighting Blindness, Midwest Eye Bank and Transplantation Center, as well as other foundations. Dr. Zacks has received numerous honors and is a member of various societies, including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Retina Society, the Macula Society and the American Society of Retina Specialists. Dr. Zacks is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy. Dr. Zacks is board certified in Ophthalmology.

Rajesh Rao is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Gyrate Atrophy of the Choroid and Retina. Dr. Rao is board certified in Ophthalmology.

Joshua Stein is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Stein is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Trabeculectomy, and Cataract Removal.

Michael Huvard, MD, is a ClinicalAssistant Professor in the Departments of Ophthalmology & VisualSciences. He earned his undergraduate degree in Philosophyat Northwestern University, where he graduated summa cum laude andwas inducted into Phi Beta Kappa. He then completed a post-baccalaureateresearch fellowship at the National Institutes of Health. He earned his medicaldegree from the University of Illinois Chicago College of Medicine, wherehe was inducted into the Alpha Omega Alpha medical honor society. Followingmedical school, he completed his ophthalmology residency at the Universityof Michigan Kellogg Eye Center. During residency he was awarded the2018 Walter R. Parker Resident Teaching Award. He subsequently completeda 2-year fellowship in Vitreoretinal Diseases and Surgery at theUniversity of Colorado Sue Anschutz-Rodgers Eye Center. He is now on faculty atthe University of Michigan Kellogg Eye Center, where he is dedicated toproviding outstanding patient care and training the next generation ofophthalmologists. The focus of his research is better definingthe clinical outcomes of diseases and surgery of the retina and vitreous,such as retinal detachments and posterior segment infectious and inflammatorydisorders, and improving medical and surgical education for medical trainees. Dr. Huvard is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Diabetic Retinopathy, Endophthalmitis, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Huvard is board certified in Ophthalmology.

Grant M. Comer, M.D., specializes in diseases and surgery of the retina and vitreous, including diagnosis and treatment of ocular melanoma retinal detachments, diabetic retinopathy, age-related macular degeneration (AMD), retinal vascular disease, ocular trauma, infectious chorioretinitis, and surgical management of complex retinal detachments.His research interests range from developing alternative treatment regimens for retinal diseases, including AMD and endophthalmitis, to studying the cost-effectiveness of vitreoretinal care and maximizing patient satisfaction through multimedia-based patient education.Dr. Comer received his medical degree from Indiana University in 2001. Following an internship at Methodist Hospital in Indianapolis, he completed a residency in ophthalmology at IU in 2005. From 205 to 2007 he undertook a vitreoretinal, uveitis and ocular oncology fellowship at the University of Michigan Kellogg Eye Center, and served as a clinical lecturer in the Department of Ophthalmology and visual Sciences from 2005 to 2009. In 2009, he earned a Master of Science in clinical research design and statistical analysis from the University of Michigan’s School of Public Health. His bibliography reflects 12 peer-reviewed papers, two book chapters, and several abstracts, as well as educational materials for patients. Dr. Comer is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Comer is board certified in Ophthalmology.

Doctor Jennifer Wyckoff is a Clinical Professor of Internal Medicine in the Metabolism, Endocrinology and Diabetes/Podiatry Division. She received her MD degree from the University of South Florida in 1992 and completed her Internal Medicine Residency at the University of Utah in 1995. In addition, Dr. Wyckoff completed a fellowship in Endocrinology at the Brigham and Women's Hospital, Harvard Medical School, in 1999. Following that, she joined the faculty of the Joslin Diabetes Center, Harvard Medical School. While there, she practiced as part of the multidisciplinary Diabetes and Pregnancy program, a joint venture between the Joslin Diabetes Center and the Beth Israel Deaconess Hospital.In 2006, she joined the faculty at University of Michigan. Dr. Wyckoff serves as the Associate Clinical Chief for the Metabolism, Endocrinology and Diabetes/Podiatry Division and the Medical Director of the Adult Diabetes Education. Her clinical interests center on diabetes, with specific emphasis on diabetes and pregnancy, Type 1 diabetes and technology, patient education and cystic fibrosis related diabetes. Dr. Wyckoff is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Secondary Immunodeficiency (SID), and Gestational Diabetes. Dr. Wyckoff is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

William H. Herman is the Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes, Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes and Professor of Epidemiology in the School of Public Health. He completed his undergraduate degree at Yale University and received his medical degree from Boston University. He gained a Masters of Public Health (Epidemiology) from the University of Michigan. Professor Herman's interests include clinical diabetes and diabetes epidemiology, especially in the areas of surveillance, screening, treatment, cost-effective analysis, and health policy. He has authored more than 400 original research papers, reviews and textbook chapters and is U-M Principal Investigator for the Diabetes Control and Complications Trial (DCCT), Epidemiology of Diabetes Interventions and Complications (EDIC), Diabetes Prevention Program (DPP), Diabetes Prevention Program Outcomes Study (DPPOS), and The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Professor Herman received the American Diabetes Association's Kelly West Award for outstanding achievement in diabetes epidemiology in 2006 and the U-M Dean's Award for Clinical and Health Services Research in 2007. From 2018 to 2021, he chaired the National Clinical Care Commission, a federal advisory committee charged with advising the Congress how to leverage federal policies and programs to better prevent and control diabetes in the United States. He has been recognized by Best Doctors as a Best Doctor in America for more than 10 years. Dr. Herman is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), Diabetic Neuropathy, and Gastric Bypass. Dr. Herman is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Thomas Wubben is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Wubben is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Cataract Removal. Dr. Wubben is board certified in Ophthalmology.

Jennifer Iyengar is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Iyengar is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Thyroid Nodule, Paget's Disease of Bone, and Type 2 Diabetes (T2D).

Jennifer Franzese is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Franzese is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Thyroid Nodule.

Dr. Lynn Ang is currently a Clinical Associate Professor in the Metabolism, Endocrinology, and Diabetes Division, Internal Medicine Department at University of Michigan. Dr. Ang is one of the principle attending physicians for the Diabetes Transition Program. Dr. Ang’s clinical and research interests are in the fields of implementing optimal management of inpatient and outpatient hyperglycemia, creating protocols for inpatient hospital guidelines, identifying biomarkers to predict the development or progression of diabetic complications, detecting the earliest stages of complications to prevent progression of diseases, and developing sensitive diagnostic methods/treatment for those complications. Dr. Ang also serves as a Co-Director of Hospital Intensive Insulin Program. Dr. Ang has been actively involving in teaching internal medicine and podiatry residents, endocrinology fellows, and medical students in both ambulatory and inpatient clinical settings. She was a recipient of Goran Sundkvist Young Investigators Award for Clinical Science 2022. Dr. Ang is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Neuropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Ang is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Nazanene H. Esfandiari, MD, is a Clinical Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes (MEND). Dr. Esfandiari received her medical degree from the University of Bordeaux in France, completed internal medicine residency in France and at UMASS Memorial Health Center in Massachusetts, and then completed fellowship in endocrinology at the University of Michigan. She joined the faculty at the University of Michigan in 2003. She was inducted into Clinical Excellence Society at the University of Michigan in 2014. She is the MEND Service Chief, Co-director of Hospital Intensive Insulin Program (HIIP) and Assistant Chief for the Inpatient Endocrine Consult.Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid disorders, post bariatric care, and diabetes. She is also interested in medical education and is the Co-director of the Endocrine Sequence at the University of Michigan Medical School. In addition, Dr. Esfandiari has served in several national committees at the Endocrine Society and American Thyroid Association (ATA). Dr. Esfandiari is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Gastric Bypass, and Thyroidectomy. Dr. Esfandiari is board certified in Endocrinology, Diabetes & Metabolism.

Zahrae Sandouk M.D., is a Clinical Assistant Professor, board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism and a graduate from Henry Ford Hospital and Cleveland Clinic who has an interest in Diabetes mellitus, Diabetes complications, Cystic Fibrosis related Diabetes, Pituitary disorders, Prolactinoma, Hypopituitarism, Thyroid disorders, Bone and calcium disorders, Adrenal and Osteoporosis. Also the medical director of the Endocrine Testing Unity at the University of Michigan where dynamic studies are performed and is also part of the Cystic Fibrosis multidisciplinary team. Dr. Sandouk is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 39 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Adrenal Insufficiency Pediatric, Type 2 Diabetes (T2D), and Thyroid Nodule. Dr. Sandouk is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Kraftson specializes in treating patients with excess weight/obesity in addition to seeing patients with general endocrinologic conditions. He was inducted into the Clinical Excellence Society in 2021. He is the Director of the Weight Navigation Program & the Director of the Post Bariatric Endocrinology Clinic. Dr. Kraftson's research, focuses on gaining a better understanding of delivering effective care for individuals with obesity. In addition to these interests, Dr. Kraftson is actively involved in medical education and is the Associate Program Director for the M.E.N.D. Endocrinology Fellowship. Dr. Kraftson is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Obesity, Malnutrition, Type 2 Diabetes (T2D), Gastric Bypass, and Sleeve Gastrectomy. Dr. Kraftson is board certified in Endocrinology, Diabetes & Metabolism.

Nevin Ajluni, M.D., joined the team at the Division of Metabolism, Endocrinology & Diabetes (MEND) after serving a two-year endocrinology fellowship in the Division. She is a part of the care team in the MEND Weight Management Program, where she works with obese individuals by applying cutting-edge research findings and novel clinical strategies. She is an honors graduate of the Wayne State University School of Medicine and completed her internship and residency in internal medicine at the McGaw Medical Center of Northwestern University before coming to the University of Michigan. Dr. Ajluni is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Familial Partial Lipodystrophy, Type 2 Diabetes (T2D), and Congenital Generalized Lipodystrophy. Dr. Ajluni is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Liselle Douyon is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Douyon is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Juvenile Primary Osteoporosis.

Cristina Nieves is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Nieves is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Nieves is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.